SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

AGM Trading Update

20 May 2025 07:00

RNS Number : 2492J
Forterra plc
20 May 2025
 

20 May 2025

FORTERRA PLC

 

AGM Trading Update

 

An encouraging start to the year

 

Ahead of our AGM which will be held today at 12.00pm in Northampton, Forterra plc (the 'Group'), a leading UK manufacturer of essential clay and concrete building products, provides this trading update for the four-month period ended 30 April 2025 ('the Period').

 

Revenue in the Period of £124.1m was 22% ahead of the prior year (£102.0m) with a strong performance in both our Bricks and Blocks and Bespoke Products operating segments.

 

Trading saw continued positive momentum with the Group benefitting from an improving demand environment, primarily driven by housebuilding with RM&I demand remaining subdued. Our own performance is consistent with an improving market backdrop, in which domestic brick despatches to the end of March, as reported by the Department for Business and Trade, increased 17% year on year albeit against soft comparatives.

 

We continue to implement the necessary selling price increases to offset cost inflation, which remains at normalised levels in line with our expectations. With demand recovering and inventories reducing we are actively managing production capacity to ensure we continue to address customer demand. We have recently taken steps to increase our production of concrete floor beams, and we are preparing to increase our brick production at Desford and expect to utilise both kilns simultaneously for the first time from Q4 2025. Whilst full output is not yet required, this marks an important milestone in the ramp-up of this facility.

 

We have made good progress with the reinstatement of our Wilnecote brick factory following an investment of around £30m, with the kiln expected to be lit imminently. We expect to begin regaining our position in the attractive commercial and specification market as the year progresses. Similarly, the commissioning of our innovative brick slip production facility at our Accrington factory continues to progress in line with our expectations as we develop the product range ahead of a market launch later this year.

 

Notwithstanding normal seasonal trends, we continue to reduce our leverage, with net debt before leases at 30 April 2025 of £88.4m (31 December 2024: £84.9m) and 30 April 2024: £118.5m) equating to 1.7 times EBITDA on a rolling 12 months' banking covenant basis (31 December 2024: 1.9 times). 

 

Outlook

 

We are encouraged by the positive start to the year and expect to continue to benefit from an improving demand environment whilst noting that the prior year comparatives become more challenging as the year progresses. We remain mindful of the presently heightened global macro-economic uncertainty and the impact this could have on the wider economy. Accordingly, at this stage in the year, the Board's expectations for the Group's full year 2025 performance remain unchanged.

 

Our key markets continue to benefit from attractive fundamentals including the Government's commitment to materially increase housebuilding, although we remain mindful of the challenges in delivering this. Following our recent strategic investments in additional manufacturing capacity, the Group remains ideally positioned to benefit from continued market recovery.

 

ENQUIRIES

 

 

 

Forterra plc

+44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting

+44 203 727 1340

Richard Mountain / Nick Hasell

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTALMTTMTMBBMA
Date   Source Headline
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company
3rd Aug 20212:49 pmRNSEmployee Benefit Trust Share Purchase
29th Jul 20217:56 amRNSProgressive publishes new research
29th Jul 20217:00 amRNSHalf-year Report
13th Jul 20216:03 pmRNSDirector/PDMR Shareholding
5th Jul 202111:22 amRNSEmployee Benefit Trust Share Purchase
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research
26th Jan 20217:00 amRNSTrading Statement
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.